Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2006-1-6
pubmed:abstractText
We used dual-color in vivo cellular imaging to visualize trafficking, nuclear-cytoplasmic dynamics, and the viability of cancer cells after their injection into the portal vein of mice. For these studies, we used dual-color fluorescent cancer cells that express green fluorescent protein (GFP) linked to histone H2B in the nucleus and retroviral red fluorescent protein (RFP) in the cytoplasm. Human HCT-116-GFP-RFP colon cancer and mouse mammary tumor (MMT) cells were HCT-116-GFP-RFP in the portal vein of nude mice. The cells were observed intravitally in the liver at the single-cell level using the Olympus OV100 whole-mouse imaging system. Most HCT-116-GFP-RFP cells remained in sinusoids near peripheral portal veins. Only a small fraction of the cancer cells invaded the lobular area. Extensive clasmocytosis (destruction of the cytoplasm) of the HCT-116-GFP-RFP cells occurred within 6 hours. The number of apoptotic cells rapidly increased within the portal vein within 12 hours of injection. Apoptosis was readily visualized in the dual-color cells by their altered nuclear morphology. The data suggest rapid death of HCT-116-GFP-RFP cells in the portal vein. In contrast, dual-color MMT-GFP-RFP cells injected into the portal vein mostly survived in the liver of nude mice 24 hours after injection. Many surviving MMT-GFP-RFP cells showed invasive figures with cytoplasmic protrusions. The cells grew aggressively and formed colonies in the liver. However, when the host mice were pretreated with cyclophosphamide, the HCT-116-GFP-RFP cells also survived and formed colonies in the liver after portal vein injection. These results suggest that a cyclophosphamide-sensitive host cellular system attacked the HCT-116-GFP-RFP cells but could not effectively kill the MMT-GFP-RFP cells.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0008-5472
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
66
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
303-6
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:16397243-Animals, pubmed-meshheading:16397243-Cell Growth Processes, pubmed-meshheading:16397243-Cell Nucleus, pubmed-meshheading:16397243-Cell Survival, pubmed-meshheading:16397243-Colonic Neoplasms, pubmed-meshheading:16397243-Cyclophosphamide, pubmed-meshheading:16397243-Cytoplasm, pubmed-meshheading:16397243-Green Fluorescent Proteins, pubmed-meshheading:16397243-HCT116 Cells, pubmed-meshheading:16397243-Humans, pubmed-meshheading:16397243-Image Processing, Computer-Assisted, pubmed-meshheading:16397243-Liver Neoplasms, Experimental, pubmed-meshheading:16397243-Luminescent Proteins, pubmed-meshheading:16397243-Male, pubmed-meshheading:16397243-Mammary Neoplasms, Experimental, pubmed-meshheading:16397243-Mice, pubmed-meshheading:16397243-Mice, Nude, pubmed-meshheading:16397243-NIH 3T3 Cells, pubmed-meshheading:16397243-Neoplastic Cells, Circulating, pubmed-meshheading:16397243-Portal Vein
pubmed:year
2006
pubmed:articleTitle
Dual-color imaging of nuclear-cytoplasmic dynamics, viability, and proliferation of cancer cells in the portal vein area.
pubmed:affiliation
AntiCancer, Inc., San Diego, California 92111, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural